Melatrit S Ing

• Malaria treatment: Kills malaria parasites in the blood when a clinician decides that injectable artesunate is needed; it is not a preventive treatment.
• Need for injectable treatment: Provides artesunate when oral treatment is not possible, with the treating team deciding what additional malaria care is required.

• Headache: Artesunate treatment or the malaria infection may cause head pain. Tell the treating team if it is severe, sudden or associated with confusion.
• Dizziness: You may feel light-headed during treatment or while recovering from malaria. Sit or lie down and ask for help before walking.
• Weakness: Malaria and artesunate can leave you tired or weak. Tell your doctor if weakness worsens or prevents normal activity.
• Loss of appetite: Reduced interest in food may occur during malaria treatment. Tell the medical team if you cannot maintain fluids or food.
• Injection-site reaction: Pain, redness or swelling can occur where the injection is given. Tell the nurse if swelling spreads or becomes increasingly painful.

• Receive Melatrit S Ing injection only from a trained healthcare professional.
• Follow the complete treatment plan advised by your doctor, including any additional antimalarial medicine.
• Drink fluids if your doctor allows and report worsening fever, confusion or breathing difficulty.
• Tell the medical team about all medicines, vitamins and supplements you use.
• Attend follow-up checks and seek urgent care if unusual tiredness, dark urine or yellowing of the skin or eyes develops after treatment.

Overdose

Missed a Dose

Interactions with other medicines